European Archives - Page 986 of 1021 - European Medical Journal

Continue
3 Dec 2014

The Geographic Variance of Helicobacter Pylori Infection in Europe and its Impact on the Incidence of Gastric Cancer

The discovery of Helicobacter pylori was hopeful as this agent was included in the list of ‘preventable- infectious carcinogens’, and many non-treatable…
3 Dec 2014

Managing Complicated Diverticular Disease in 2014

Complicated diverticular disease refers to patients who present with abscess, peritonitis, bleeding, fistula, or bowel obstruction. Management paradigms…
3 Dec 2014

Understanding Exercise-Associated Hyponatraemia: From Pathophysiology to Treatment

The practice of extreme sports is becoming more and more common. Despite physiological adaptation, people who intensively exercise are exposed to…
December 2014

EMJ Gastroenterology 3.1 2014

Innovation, best-practice, improving patient outcomes and quality of life, and new endeavours are all areas which this edition of European Medical…
EMJ
2 Dec 2014

UEG Puts the Need for Better Care for IBD Patients in Europe on the Political Agenda

(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs…
1 Dec 2014

Inherited Bone Marrow Failure Syndromes with Pancytopaenia

Bone marrow failure (BMF) is characterised by a reduction in the effective production of mature erythrocytes, granulocytes, and platelets by the bone…
EMJ
28 Nov 2014

Infecciones urinarias recurrentes: resistencia a los antibióticos y directrices

La aparición y propagación de la resistencia a los antibióticos (RAB) es un factor crítico en la salud general y el bienestar. Debido a su prevalencia…
EMJ
28 Nov 2014

Introducción a la carga que supone la cystitis recurrente y la justificación de la prevención

Esta cumbre, de carácter educativo y financiada por una beca independiente de OM/Vifor Pharma, ha reunido a expertos en urología y ginecología procedentes…
EMJ
28 Nov 2014

Infecciones urinarias en grupos de población específicos y polémica en torno al tratamiento de la enfermedad

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/ViforPharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27 de abril de 2014
EMJ
28 Nov 2014

Introduction to the Burden of Recurrent Cystitis and Rationale for Prevention

This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together experts in the field of urology and gynaecology…